ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,039Medicare Part D Prescriptions Filled, Including Refills

Rank: 115 out of 890

$795K Total Retail Price of All Prescriptions

Rank: 101 out of 890

445 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
83% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

18% of this provider’s 445 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 9,965 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
AMLODIPINE BESYLATE 716 519 1 1
OMEPRAZOLE 476 363 2 8
AMLODIPINE BESYLATE-BENAZEPRIL 435 315 3 41
HYDROCHLOROTHIAZIDE 433 262 4 9
METFORMIN HCL 412 279 5 6
PRAVASTATIN SODIUM 355 244 6 10
POTASSIUM CHLORIDE 291 212 7 11
HYDROCODONE-ACETAMINOPHEN 269 229 S3 8 3
SIMVASTATIN 253 193 9 5
DIOVAN HCT 221 151 10 48
ATORVASTATIN CALCIUM 211 170 11 13
FUROSEMIDE 200 142 12 7
SYNTHROID 189 118 13 53
CARVEDILOL 188 158 14 22
LISINOPRIL 181 109 15 4
NEXIUM 178 126 16 14
ZOLPIDEM TARTRATE 177 109 17 19
SINGULAIR 172 93 18 79
CLONIDINE HCL 171 74 19 35
NATEGLINIDE 170 117 20 251
BENAZEPRIL HCL 168 128 21 44
WARFARIN SODIUM 155 131 22 24
LANTUS 136 86 23 50
GABAPENTIN 135 81 24 12
MELOXICAM 131 78 25 18
SUCRALFATE 131 92 25 158
BYSTOLIC 128 98 27 86
DIOVAN 128 106 27 33
CRESTOR 126 100 29 25
MONTELUKAST SODIUM 121 68 30 130
SPIRIVA 119 106 31 66
CLOPIDOGREL 117 102 32 28
GLIMEPIRIDE 114 60 33 27
METOPROLOL SUCCINATE 110 101 34 17
CYCLOBENZAPRINE HCL 108 70 R 35 64
LYRICA 107 75 36 71
TRIAMTERENE-HCTZ 103 82 37 61
PANTOPRAZOLE SODIUM 96 64 38 34
DIGOXIN 94 81 39 65
ALLOPURINOL 94 65 39 31
CILOSTAZOL 93 89 41 223
FELODIPINE ER 89 76 42 187
NAMENDA 86 74 43 36
METOPROLOL TARTRATE 86 69 43 15
INSULIN SYRINGE 85 52 45 99
GLIPIZIDE XL 83 53 46 128
ESCITALOPRAM OXALATE 82 49 47 51
ISOSORBIDE MONONITRATE ER 81 62 48 60
GLIPIZIDE 80 58 49 62
FENOFIBRATE 79 50 50 74
SPIRONOLACTONE 78 47 51 85
TAMSULOSIN HCL 77 69 52 32
LEVOTHYROXINE SODIUM 76 62 53 2
PLAVIX 76 70 53 42
METOLAZONE 76 62 53 217
LIPITOR 75 60 56 77
CYMBALTA 73 36 57 45
LOVAZA 72 41 58 120
DEXILANT 72 46 58 138
NIFEDIPINE ER 68 50 60 75
FAMOTIDINE 68 65 60 90
LOSARTAN POTASSIUM 62 62 62 29
AMITRIPTYLINE HCL 62 62 R 62 43
LISINOPRIL-HYDROCHLOROTHIAZIDE 62 47 62 21
DONEPEZIL HCL 60 44 65 30
JANUMET 60 54 65 194
LOSARTAN-HYDROCHLOROTHIAZIDE 59 52 67 57
LABETALOL HCL 56 27 68 208
RAMIPRIL 56 50 68 80
GLIPIZIDE ER 56 43 68 110
PROAIR HFA 52 38 71 55
PHENYTOIN SODIUM EXTENDED 52 18 71 111
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 24, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.